Clinical trial

Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions

NCT02075619

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Amlodipine+Rosuvastatin Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention GSK3074477 FDC - 1 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention GSK3074477 FDC - 2 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-03-24

PhasePHASE1

Conditions

Hypertensionunresolved

Interventions

Amlodipine+RosuvastatinDRUG

GSK3074477 FDC - 1DRUG

GSK3074477 FDC - 2DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

SingHealth Investigational Medicine Unit, Singaporecollaborator

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02075619 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.